Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma - Sunwoo, J B; Chen, Z; Dong, G (Clinical Cancer Research., 2001)
et al.